EVMN Evommune, Inc.
Healthcare$22.87-2.89%ClosedMarket Cap: $323.9M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
2.53
P/S
32.39
EV/EBITDA
-3.60
DCF Value
$-64.25
FCF Yield
-24.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
92.8%
Operating Margin
-899.9%
Net Margin
-759.9%
ROE
-195.2%
ROA
-23.6%
ROIC
-28.7%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-24.0M | $-21.7M | $— | — |
| Q4 null | $0.00 | NaN% | $-29.7M | $-28.3M | $— | — |
| FY null | $13.0M | 100.0% | $-81.1M | $-68.9M | $— | — |
| Q3 null | $10.0M | 100.0% | $-13.3M | $-12.5M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-23.0M | $-13.6M | $— | — |
| Q1 null | $3.0M | 87.4% | $-15.0M | $-14.6M | $— | — |
| Q4 null | $0.00 | NaN% | $-19.0M | $-18.3M | $— | — |
| FY null | $7.0M | 81.6% | $-70.0M | $-66.8M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-28.3M | $-27.4M | $— | — |
| Q1 null | $7.0M | 96.1% | $-3.8M | $-2.8M | $— | — |
| FY null | $5.0M | 80.0% | $-37.9M | $-34.1M | $— | — |